Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Biomedical and Engineering Education · Artificial Intelligence in Healthcare and Education
In the Research Letter titled “Use of Artificial Intelligence in Drug Development,”^1^ published May 31, 2024, 2 percentages in the Results section were given incorrectly. The percentage of drugs for which AI was used for a cancer indication should have appeared as 32% instead of 27%, and the number and percentage of drugs for which AI was used for a neurological indication should have appeared as n = 46 and 28% instead of 24%. This article has been corrected.^1^
The reference list from the paper itself. Each links out to its DOI / PubMed record.